Sarah C Moser

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Drug Administration

Top Venues

Nature reviews. Clinical oncology

Science advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Petra Ter Brugge, Sarah C Moser, Ivan Bièche, Petra Kristel, Sabrina Ibadioune, Alexandre Eeckhoutte, Roebi de Bruijn, Eline van der Burg, Catrin Lutz, Stefano Annunziato, Julian de Ruiter, Julien Masliah Planchon, Sophie Vacher, Laura Courtois, Rania El-Botty, Ahmed Dahmani, Elodie Montaudon, Ludivine Morisset, Laura Sourd, Léa Huguet, Heloise Derrien, Fariba Nemati, Sophie Chateau-Joubert, Thibaut Larcher, Anne-Vincent Salomon, Didier Decaudin, Fabien Reyal, Florence Coussy, Tatiana Popova, Jelle Wesseling, Marc-Henri Stern, Jos Jonkers, Elisabetta Marangoni
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers. Nature communications 14 (1) (2023)
Abdelghani Mazouzi, Sarah C Moser, Federico Abascal, Bram van den Broek, Martin Del Castillo Velasco-Herrera, Ingrid van der Heijden, Maarten L Hekkelman, Anne Paulien Drenth, Eline van der Burg, Lona J Kroese, Kees Jalink, David J Adams, Jos Jonkers, Thijn R Brummelkamp
FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks. Science advances 9 (22) (2023)
Mariana Paes Dias, Sarah C Moser, Shridar Ganesan, Jos Jonkers
Understanding and overcoming resistance to PARP inhibitors in cancer therapy. Nature reviews. Clinical oncology 18 (12) (2021)